Laboratory techniques for human viral encephalitis diagnosis

Infectious Disorders - Drug Targets

Volumn 11, Issue 3, 2011, Pages 206-234

  Mutton, Kenneth ^a   Guiver, Malcolm ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Diagnosis; Encephalitis; Intrathecal antibody; Molecular

Indexed keywords

GLUCOSE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LACTIC ACID; LOCKED NUCLEIC ACID; NEOPTERIN; PROTEIN; VIRUS ANTIGEN;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ANTIBODY PRODUCTION; ANTIGEN DETECTION; ARBOVIRUS; ARTICLE; BRAIN BIOPSY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; DNA MICROARRAY; ELECTROENCEPHALOGRAPHY; ELECTRON MICROSCOPY; ENCEPHALITIS; ENTEROVIRUS; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; LEUKOCYTE DIFFERENTIAL COUNT; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR BEACON; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEIC ACID AMPLIFICATION; POINT OF CARE TESTING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS ENCEPHALITIS; VIRUS LOAD;

EID: 79958258174     PISSN: 18715265     EISSN: 18755852     Source Type: Journal    
DOI: 10.2174/187152611795768042     Document Type: Article

References (361)

1. Kennedy, P. Viral encephalitis. J. Neurol.,2005, 252, 268-272.
2. Whitley, R. J.; Gnann, J. W. Viral encephalitis: familiar infections and emerging pathogens. Lancet, 2002, 359, 507-513.
3. WHO. Distribution of risk levels for humans contractingrabies,worldwide,2009. http://gamapserver.who.int/mapLibrary/Files/Maps/Global_rabies_2009.png (accessed November 30, 2010).
4. Knobel, D.; Cleaveland, S.; Coleman, P.; Fèvre, E.; Meltzer, M.; Miranda, M.; Shaw, A.; Zinsstag, J.; Meslin, F. Re-evaluating the burden of rabies in Africa and Asia. Bull. World Health Organ., 2005, 83, 360-368.
5. Erlanger, T. E.; Weiss, S.; Keiser, J.; Utzinger, J.; Wiedenmayer, K. Past, present, and future of Japanese encephalitis. Emerg. Infect. Dis., 2009, 15, 1-7.
6. Solomon, T. Control of Japanese encephalitis--within our grasp? N. Engl.J.Med., 2006, 355, 869-871.
7. Donoso Mantke, O.; Vaheri, A.; Ambrose, H.; Koopmans, M.; de Ory, F.; Zeller, H.; Beyrer, K.; Windorfer, A.; Niedrig, M. Analysis of the surveillance situation for viral encephalitis and meningitis in Europe. Euro. Surveill., 2008, 13, pii=8017.
8. Tunkel, A. R.; Glaser, C. A.; Bloch, K. C.; Sejvar, J. J.; Marra, C. M.; Roos, K. L.; Hartman, B. J.; Kaplan, S. L.; Scheld, W. M.; Whitley, R. J. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis., 2008, 47, 303-327.
9. Miller, J.; Ross, C. Encephalitis. A four-year survey. Lancet, 1968, 1 (7552), 1121-1126.
10. Granerod, J.; Ambrose, H. E.; Davies, N. W.; Clewley, J. P.; Walsh, A. L.; Morgan, D.; Cunningham, R.; Zuckerman, M.; Mutton, K. J.; Solomon, T.; Ward, K. N.; Lunn, M. P.; Irani, S. R.; Vincent, A.; Brown, D. W.; Crowcroft, N. S. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect. Dis., 2010, 10, 835-844.
11. Grist, N.; Ross, C.; Bell, E.; Stott, E. Diagnostic Methods in Clinical Virology. Oxford University Press: Oxford, 1966.
12. Granerod, J.; Cunningham, R.; Zuckerman, M.; Mutton, K.; Davies, N. W.; Walsh, A. L.; Ward, K. N.; Hilton, D. A.; Ambrose, H. E.; Clewley, J. P.; Morgan, D.; Lunn, M. P.; Solomon, T.; Brown, D. W.; Crowcroft, N. S. Causality in acute encephalitis: defining aetiologies. Epidemiol. Infect., 2010, 138, 783-800.
13. Huppatz, C.; Kelly, P.; Levi, C.; Dalton, C.; Williams, D.; Durrheim, D. Encephalitis in Australia, 1979-2006: trends and aetiologies. Commun.Dis. Intell.,2009, 33, 192-197.
14. Glaser, C.; Gilliam, S.; Schnurr, D.; Forghani, B.; Honarmand, S.; Khetsuriani, N.; Fischer, M.; Cossen, C.; Anderson, L. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin. Infect. Dis., 2003, 36, 731-742.
15. Davison, K.; Crowcroft, N.; Ramsay, M.; Brown, D.; Andrews, N. Viral encephalitis in England, 1989-1998: what did we miss? Emerg. Infect. Dis., 2003, 9, 234-240.
16. Koskiniemi, M.; Rantalaiho, T.; Piiparinen, H.; von Bonsdorff, C. H.; Farkkila, M.; Jarvinen, A.; Kinnunen, E.; Koskiniemi, S.; Mannonen, L.; Muttilainen, M.; Linnavuori, K.; Porras, J.; Puolakkainen, M.; Raiha, K.; Salonen, E. M.; Ukkonen, P.; Vaheri, A.; Valtonen, V. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J. Neurovirol., 2001, 7, 400-408.
17. Mailles, A.; Stahl, J. Infectious encephalitis in France in 2007: a national prospective study. Clin. Infect. Dis., 2009, 49, 1838-1847.
18. Gable, M.; Gavali, S.; Radner, A.; Tilley, D.; Lee, B.; Dyner, L.; Collins, A.; Dengel, A.; Dalmau, J.; Glaser, C. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur. J. Clin. Microbiol. Infect. Dis., 2009, 28, 1421-1429.
19. Florance, N. R.; Davis, R. L.; Lam, C.; Szperka, C.; Zhou, L.; Ahmad, S.; Campen, C. J.; Moss, H.; Peter, N.; Gleichman, A. J.; Glaser, C. A.; Lynch, D. R.; Rosenfeld, M. R.; Dalmau, J. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann. Neurol., 2009, 66, 11-18.
20. Reid, J.; Foley, P.; Willison, H. Voltage-gated potassium channel-associated limbic encephalitis in the West of Scotland: case reports and literature review. Scott. Med. J., 2009, 54, 27-31.
21. Thieben, M. J.; Lennon, V. A.; Boeve, B. F.; Aksamit, A. J.; Keegan, M.; Vernino, S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology, 2004, 62, 1177-1182.
22. Garg, R. K. Subacute sclerosing panencephalitis. J.Neurol., 2008, 255, 1861-1871.
23. Griffin, D. E. Measles and rubella. In: Infections of the Central Nervous System, 3rd ed.; Scheld, W. M.; Whitley, R. J.; Marra, C. M., Eds., Lippincott Williams & Wilkins: Philadelphia, PA, 2004; pp 111-122.
24. Booss, J.; Esiri, M. M. Encephalitis in Immunocompromised Patients. In: Viral Encephalitis in Humans, ASM Press: Washington, DC, 2003; pp 221-236.
25. Tenembaum, S.; Chitnis, T.; Ness, J.; Hahn, J. S. Acute disseminated encephalomyelitis. Neurology, 2007, 68 (Suppl 2), S23-S36.
26. Stonehouse, M.; Gupte, G.; Wassmer, E.; Whitehouse, W. P. Acute disseminated encephalomyelitis: recognition in the hands of general paediatricians. Arch. Dis. Child, 2003, 88, 122-124.
27. Menge, T.; Hemmer, B.; Nessler, S.; Wiendl, H.; Neuhaus, O.; Hartung, H. P.; Kieseier, B. C.; Stuve, O. Acute disseminated encephalomyelitis: an update. Arch.Neurol., 2005, 62, 1673-1680.
28. Sonneville, R.; Klein, I. F.; Wolff, M. Update on investigation and management of postinfectious encephalitis. Curr.Opin.Neurol., 2010, 23, 300-304.
29. Booss, J.; Esiri, M. M. Diagnostic Evaluation. In: Viral Encephalitis in Humans, ASM Press: Washington,DC, 2003; pp 21-30.
30. Maschke, M.; Kastrup, O.; Forsting, M.; Diener, H. C. Update on neuroimaging in infectious central nervous system disease. Curr.Opin.Neurol., 2004, 17, 475-480.
31. Davies, N. W.; Sharief, M. K.; Howard, R. S. Infection-associated encephalopathies: their investigation, diagnosis, and treatment. J. Neurol., 2006, 253, 833-845.
32. Chonmaitree, T.; Baldwin, C.; Lucia, H. Role of the virology laboratory in diagnosis and management of patients with central nervous system disease. Clin. Microbiol.Rev., 1989, 2, 1-14.
33. Debiasi, R.; Tyler, K. Molecular methods for diagnosis of viral encephalitis. Clin. Microbol.Rev., 2004, 17, 903-925.
34. Booss, J.; Esiri, M. M. Pathological Features of Encephalitis in Humans. In: Viral Encephalitis in Humans, ASM Press Washington, DC, 2003; pp 3-19.
35. Bentivoglio, M. Intraneuronal inclusion bodies: from Negri bodies to proteasomal dysfunction. Rend. Fis. Acc. Lincei., 2003, 14, 263-279.
36. White, C. L., 3rd; Taxy, J. B. Early morphologic diagnosis of herpes simplex virus encephalitis: advantages of electron microscopy and immunoperoxidase staining. Hum.Pathol., 1983, 14, 135-139.
37. Dubois-Dalcq, M.; Coblentz, J. M.; Pleet, A. B. Subacute sclerosing panencephalitis. Unusual nuclear inclusions and lengthy clinical course. Arch. Neurol., 1974, 31, 355-363.
38. th ed.; WHO: 1996; p 65.
39. WHO Expert Consultation on Rabies. In: WHO Technical Report Series 931 [Online] first report ed.; Geneva (2004).
40. Lembo, T.; Niezgoda, M.; Velasco-Villa, A.; Cleaveland, S.; Ernest, E.; Rupprecht, C. E. Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis. Emerg. Infect. Dis., 2006, 12, 310-313.
41. Sköldenberg, B.; Forsgren, M.; Alestig, K.; Bergström, T.; Burman, L.; Dahlqvist, E.; Forkman, A.; Frydén, A.; Lövgren, K.; Norlin, K. Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet, 1984, 2, 707-711.
42. Whitley, R.; Alford, C.; Hirsch, M.; Schooley, R.; Luby, J.; Aoki, F.; Hanley, D.; Nahmias, A.; Soong, S. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N. Engl. J. Med., 1986, 314, 144-149.
43. Cohen, B.; Levy, R. The role of brain biopsy in the diagnosis of CNS viral infections. In Clinical Neurovirology, Nath, A.; Berger, J., Eds. Marcel Dekker: New York, 2003; pp 35-41.
44. Holloway, R.; Mushlin, A. Intracranial mass lesions in acquired immunodeficiency syndrome: using decision analysis to determine the effectiveness of stereotactic brain biopsy. Neurology, 1996, 4, 1010-1015.
45. Gildenberg, P.; Gathe, J. J.; Kim, J. Stereotactic biopsy of cerebral lesions in AIDS. Clin.Infect.Dis., 2000, 30, 491-499.
46. Thoren, A.; Widell, A. PCR for the diagnosis of enteroviral meningitis. Scand. J. Infect. Dis., 1994, 26, 249-254.
47. Chung, P. W.; Huang, Y. C.; Chang, L. Y.; Lin, T. Y.; Ning, H. C., Duration of enterovirus shedding in stool. J. Microbiol. Immunol. Infect., 2001, 34, 167-170.
48. Tsao, L. Y.; Lin, C. Y.; Yu, Y. Y.; Wang, B. T. Microchip, reverse transcription-polymerase chain reaction and culture methods to detect enterovirus infection in pediatric patients. Pediatr.Int., 2006, 48, 5-10.
49. Diamond, C.; Mohan, K.; Hobson, A.; Frenkel, L.; Corey, L. Viremia in neonatal herpes simplex virus infections. Pediatr.Infect.Dis. J., 1999, 18, 487-489.
50. Juhl, D.; Mosel, C.; Nawroth, F.; Funke, A. M.; Dadgar, S. M.; Hagenstrom, H.; Kirchner, H.; Hennig, H. Detection of herpes simplex virus DNA in plasma of patients with primary but not with recurrent infection: implications for transfusion medicine? Transfus. Med.,2010, 20, 38-47.
51. Brice, S. L.; Stockert, S. S.; Jester, J. D.; Huff, J. C.; Bunker, J. D.; Weston, W. L. Detection of herpes simplex virus DNA in the peripheral blood during acute recurrent herpes labialis. J. Am. Acad. Dermatol., 1992, 26, 594-598.
52. Likos, A. M.; Kelvin, D. J.; Cameron, C. M.; Rowe, T.; Kuehnert, M. J.; Norris, P. J.; National Heart, L. Blood institute retrovirus epidemiology donor study-II (REDS-II), influenza viremia and the potential for blood-borne transmission. Transfusion, 2007, 47, 1080-1088.
53. Uchida, K.; Shinohara, M.; Shimada, S.; Segawa, Y.; Doi, R.; Gotoh, A.; Hondo, R. Rapid and sensitive detection of mumps virus RNA directly from clinical samples by real-time PCR. J. Med. Virol., 2005, 75, 470-474.
54. Boddicker, J. D.; Rota, P. A.; Kreman, T.; Wangeman, A.; Lowe, L.; Hummel, K. B.; Thompson, R.; Bellini, W. J.; Pentella, M.; Desjardin, L. E. Real-time reverse transcription-PCR assay for detection of mumps virus RNA in clinical specimens. J.Clin. Microbiol.,2007, 45, 2902-2908.
55. Ukkonen, P.; Vaisanen, O.; Penttinen, K. Enzyme-linked immunosorbent assay for mumps and parainfluenza type 1 immunoglobulin G and immunoglobulin M antibodies. J. Clin. Microbiol., 1980, 11, 319-323.
56. Fowlkes, A. L.; Honarmand, S.; Glaser, C.; Yagi, S.; Schnurr, D.; Oberste, M. S.; Anderson, L.; Pallansch, M. A.; Khetsuriani, N. Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005. J.Infect.Dis., 2008, 198, 1685-1691.
57. Bendig, J. W.; Molyneaux, P. Sensitivity and specificity of mu-capture ELISA for detection of enterovirus IgM. J. Virol.Methods, 1996, 59, 23-32.
58. Samuelson, A.; Skoog, E.; Forsgren, M. Aspects on the serodiagnosis of enterovirus infection by ELISA. Serodiagn. Immunother. Infect. Dis., 1990, 4, 395-406.
59. Muir, P.; Banatvala, J. E. Reactivity of enterovirus-specific IgM with infective and defective coxsackie B virions in patients with monotypic and multitypic IgM responses. J. Virol.Methods, 1990, 29, 209-224.
60. Betts Carpenter, A. Immunoassays for the Diagnosis of Infectious Diseases. In: Manual of Clinical Microbiology, Murray, P.; Baron, E.; Jorgensen, J.; Landry, M.; Pfaller, M., Eds., ASM Press: Washington DC, 2007; Vol. 1, pp 257-270.
61. Crepin, P.; Audry, L.; Rotivel, Y.; Gacoin, A.; Caroff, C.; Bourhy, H. Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J. Clin. Microbiol., 1998, 36, 1117-1121.
62. Feyssaguet, M.; Dacheux, L.; Audry, L.; Compoint, A.; Morize, J. L.; Blanchard, I.; Bourhy, H. Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people. Vaccine, 2007, 25, 2244-2251.
63. Wacharapluesadee, S.; Hemachudha, T. Ante- and post-mortem diagnosis of rabies using nucleic acid-amplification tests. Expert Rev. Mol. Diagn., 2010, 10, 207-218.
64. Dacheux, L.; Reynes, J. M.; Buchy, P.; Sivuth, O.; Diop, B. M.; Rousset, D.; Rathat, C.; Jolly, N.; Dufourcq, J. B.; Nareth, C.; Diop, S.; Iehlé, C.; Rajerison, R.; Sadorge, C.; Bourhy, H. A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin. Infect. Dis., 2008, 47, 1410-1417.
65. Deisenhammer, F.; Bartos, A.; Egg, R.; Gilhus, N. E.; Giovannoni, G.; Rauer, S.; Sellebjerg, F. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur. J.Neurol., 2006, 13, 913-922.
66. Kneen, R.; Solomon, T.; Appleton, R. The role of lumbar puncture in suspected CNS infection--a disappearing skill? Arch. Dis. Child, 2002, 87, 181-183.
67. Kneen, R.; Solomon, T.; Appleton, R. The role of lumbar puncture in children with suspected central nervous system infection. BMC Pediatr., 2002, 2, 8.
68. Hasbun, R.; Abrahams, J.; Jekel, J.; Quagliarello, V. J. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N. Engl. J. Med., 2001, 345, 1727-1733.
69. Greig, P. R.; Goroszeniuk, D. Role of computed tomography before lumbar puncture: a survey of clinical practice. Postgrad. Med. J., 2006, 82, 162-165.
70. Cinque, P.; Linde, A. CSF analysis in the diagnosis of viral meningitis and encephalitis. In: Clinical Neurovirology, Nath, A.; Berger, J., Eds. Marcel Dekker: New York, 2003; pp 43-107.
71. Kestenbaum, L. A.; Ebberson, J.; Zorc, J. J.; Hodinka, R. L.; Shah, S. S. Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants. Pediatrics, 2010, 125, 257-264.
72. Spanos, A.; Harrell, F. E., Jr.; Durack, D. T. Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations. JAMA, 1989, 262, 2700-2707.
73. Karandanis, D.; Shulman, J. A. Recent survey of infectious meningitis in adults: review of laboratory findings in bacterial, tuberculous, and aseptic meningitis. South. Med. J., 1976, 69, 449-457.
74. Koskiniemi, M.; Vaheri, A.; Taskinen, E. Cerebrospinal fluid alterations in herpes simplex virus encephalitis. Rev. Infect. Dis., 1984, 6, 608-618.
75. Converse, G. M.; Gwaltney, J. M., Jr.; Strassburg, D. A.; Hendley, J. O. Alteration of cerebrospinal fluid findings by partial treatment of bacterial meningitis. J.Pediatr., 1973, 83, 220-225.
76. Negrini, B.; Kelleher, K. J.; Wald, E. R. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics, 2000, 105, 316-319.
77. Modlin, J. F.; Dagan, R.; Berlin, L. E.; Virshup, D. M.; Yolken, R. H.; Menegus, M. Focal encephalitis with enterovirus infections. Pediatrics, 1991, 88, 841-845.
78. Kanegaye, J. T.; Nigrovic, L. E.; Malley, R.; Cannavino, C. R.; Schwab, S. H.; Bennett, J. E.; Mohseni, M. M.; Wang, V. J.; Katsogridakis, Y. L.; Herman, M. I.; Kuppermann, N. Diagnostic value of immature neutrophils (bands) in the cerebrospinal fluid of children with cerebrospinal fluid pleocytosis. Pediatrics, 2009, 123, e967-71.
79. Powers, W. J. Cerebrospinal fluid lymphocytosis in acute bacterial meningitis. Am. J. Med., 1985, 79, 216-220.
80. Rotbart, H. A. Enteroviral infections of the central nervous system. Clin. Infect. Dis., 1995, 20, 971-981.
81. Tavakoli, N. P.; Wang, H.; Nattanmai, S.; Dupuis, M.; Fusco, H.; Hull, R. Detection and typing of enteroviruses from CSF specimens from patients diagnosed with meningitis/encephalitis. J.Clin.Virol., 2008, 43, 207-211.
82. Landry, M. L. Frequency of normal cerebrospinal fluid protein level and leukocyte count in enterovirus meningitis. J. Clin. Virol., 2005, 32, 73-74.
83. Henquell, C.; Chambon, M.; Bailly, J. L.; Alcaraz, S.; De Champs, C.; Archimbaud, C.; Labbe, A.; Charbonne, F.; Peigue-Lafeuille, H. Prospective analysis of 61 cases of enteroviral meningitis: interest of systematic genome detection in cerebrospinal fluid irrespective of cytologic examination results. J. Clin. Virol., 2001, 21, 29-35.
84. Mulford, W. S.; Buller, R. S.; Arens, M. Q.; Storch, G. A. Correlation of cerebrospinal fluid (CSF) cell counts and elevated CSF protein levels with enterovirus reverse transcription-PCR results in pediatric and adult patients. J. Clin. Microbiol., 2004, 42, 4199-203.
85. Graham, A. K.; Murdoch, D. R. Association between cerebrospinal fluid pleocytosis and enteroviral meningitis. J. Clin. Microbiol., 2005, 43, 1491.
86. Seiden, J. A.; Zorc, J. J.; Hodinka, R. L.; Shah, S. S. Lack of cerebrospinal fluid pleocytosis in young infants with enterovirus infections of the central nervous system. Pediatr. Emerg. Care., 2010, 26, 77-81.
87. Solomon, T.; Hart, I. J.; Beeching, N. J. Viral encephalitis: a clinician's guide. Pract. Neurol., 2007, 7, 288-305.
88. Dennett, C.; Klapper, P.; Cleator, G.; Lewis, A. CSF pretreatment and the diagnosis of herpes encephalitis using the polymerase chain reaction. J. Virol. Methods, 1991, 34, 101-104.
89. Sefers, S.; Raymer, A.; Kilby, J.; Persing, D.; Tang, Y. Prevalence and management of invalid GeneXpert enterovirus results obtained with cerebrospinal fluid samples: a 2-year study. J. Clin. Microbiol., 2009, 47, 3008-3010.
90. rd ed.; Scheld, W. M.; Whitley, R. J.; Marra, C. M. Eds., Lippincott Williams & Wilkins: Philadelphia, PA, 2004.
91. Davis, R.; Jeffery, K.; Atkins, B. L. Hypoglycorrhachia in herpes simplex encephalitis. Clin.Infect.Dis., 2004, 38, 1506-1507.
92. Mommeja-Marin, H.; Lafaurie, M.; Scieux, C.; Galicier, L.; Oksenhendler, E.; Molina, J. M. Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults. Clin. Infect. Dis., 2003, 37, 1527-33.
93. Singh, N.; Anderegg, K. A.; Yu, V. L. Significance of hypoglycorrhachia in patients with AIDS and cytomegalovirus meningoencephalitis. Clin. Infect. Dis., 1993, 17, 283-284.
94. Unzek, S.; Salata, R. A.; Armitage, K. B. West Nile virus infection causing hypoglycorrhachia in an HIV-infected man: a case report. Infect. Dis. Clin. Practic, 2006, 14, 389-391.
95. Cunha, B. A. The diagnostic usefulness of cerebrospinal fluid lactic acid levels in central nervous system infections. Clin. Infect. Dis., 2004, 39, 1260-1261.
96. Komorowski, R. A.; Farmer, S. G.; Hanson, G. A.; Hause, L. L. Cerebrospinal fluid lactic acid in diagnosis of meningitis. J. Clin. Microbiol., 1978, 8, 89-92.
97. Posner, J. B.; Plum, F. Independence of blood and cerebrospinal fluid lactate. Arch. Neurol., 1967, 16, 492-496.
98. Chonmaitree, T.; Baldwin, C. D.; Lucia, H. L. Role of the virology laboratory in diagnosis and management of patients with central nervous system disease. Clin. Microbiol. Rev., 1989, 2, 1-14.
99. Nahmias, A. J.; Whitley, R. J.; Visintine, A. N.; Takei, Y.; Alford, C. A. Jr. Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J. Infect. Dis., 1982, 145, 829-836.
100. Tang, Y.; Mitchell, P.; Espy, M.; Smith, T.; Persing, D. Molecular diagnosis of herpes simplex virus infections in the central nervous system. J. Clin. Microbiol., 1999, 37, 2127-2136
101. Leland, D.; Ginocchio, C. Role of cell culture for virus detection in the age of technology. Clin. Microbiol. Rev., 2007, 20, 49-78.
102. Buck, G.; Wiesemann, M.; Stewart, L. Comparison of mixed cell culture containing genetically engineered BGMK and CaCo-2 cells (Super E-Mix) with RT-PCR and conventional cell culture for the diagnosis of enterovirus meningitis. J.Clin.Virol., 2002, 25 (Suppl 1), S13-S18.
103. Chua, K.; Goh, K.; Wong, K.; Kamarulzaman, A.; Tan, P.; Ksiazek, T.; Zaki, S.; Paul, G.; Lam, S.; Tan, C. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet, 1999, 354, 1257-1259.
104. Palacios, G.; Druce, J.; Du, L.; Tran, T.; Birch, C.; Briese, T.; Conlan, S.; Quan, P. L.; Hui, J.; Marshall, J.; Simons, J. F.; Egholm, M.; Paddock, C. D.; Shieh, W. J.; Goldsmith, C. S.; Zaki, S. R.; Catton, M.; Lipkin, W. I. A new arenavirus in a cluster of fatal transplant-associated diseases. N. Engl. J. Med., 2008, 358, 991-998.
105. Steele, R.; Keeney, R.; Bradsher, R.; Moses, E.; Soloff, B. Treatment of varicella-zoster meningoencephalitis with acyclovir--demonstration of virus in cerebrospinal fluid by electron microscopy. Am. J. Clin. Pathol., 1983, 80, 57-60.
106. Anon, Virus diagnostic scanning electronmicroscopy. Lancet, 1988, 331 (8600), 1436-1437.
107. Cheng, V. C.; Lau, S. K.; Woo, P. C.; Yuen, K. Y. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin. Microbiol. Rev., 2007, 20, 660-694.
108. Dayan, A.; Stokes, M. Rapid diagnosis of encephalitis by immunofluorescent examination of cerebrospinal-fluid cells. Lancet, 1973, 1 (7796), 177-179.
109. Bos, C.; Olding-Stenkvist, E.; Wilterdink, J.; Scheffer, A. Detection of viral antigens in cerebrospinal fluid of patients with herpes simplex virus encephalitis. J. Med. Virol., 1987, 21, 169-178.
110. Lakeman, F.; Koga, J.; Whitley, R. Detection of antigen to herpes simplex in cerebrospinal fluid from patients with herpes simplex encephalitis. J. Infect. Dis., 1987, 155, 1172-1178.
111. Klapper, P.; Cleator, G.; Lewis, A. Obstacle to early diagnosis of herpes simplex encephalitis via CSF. Lancet, 1990, 336 (8711), 385-386.
112. Kamei, S.; Takasu, T.; Morishima, T.; Yoshihara, T.; Tetsuka, T. Comparative study between chemiluminescence assay and two different sensitive polymerase chain reactions on the diagnosis of serial herpes simplex virus encephalitis. J. Neurol. Neurosurg. Psychiatry, 1999, 67, 596-601.
113. Grundy, M. A.; Moore, K.; Coakley, W. T. Increased sensitivity of diagnostic latex agglutination tests in an ultrasonic standing wave field. J. Immunol. Methods, 1994, 176, 169-77.
114. Ellis, R. W.; Sobanski, M.A. Diagnostic particle agglutination using ultrasound: a new technology to rejuvenate old microbiological methods. J. Med. Microbiol., 2000, 49, 853-859.
115. Gray, S. J.; Sobanski, M. A.; Kaczmarski, E. B.; Guiver, M.; Marsh, W. J.; Borrow, R.; Barnes, R. A.; Coakley, W. T. Ultrasound-enhanced latex immunoagglutination and PCR as complementary methods for non-culture-based confirmation of meningococcal disease. J. Clin. Microbiol., 1999, 37, 1797-801.
116. Sobanski, M. A.; Vince, R.; Biagini, G. A.; Cousins, C.; Guiver, M.; Gray, S. J.; Kaczmarski, E. B.; Coakley, W.T. Ultrasound enhanced detection of individual meningococcal serogroups by latex immunoassay. J. Clin. Pathol., 2002, 55, 37-40.
117. th ed.; Murray, P.; Baron, E.; Jorgensen, J.; Landry, M.; Pfaller, M., Eds. ASM Press: Washington,DC, 2007; Vol. 1, pp 218-244.
118. Lakeman, F.; Whitley, R. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J. Infect. Dis., 1995, 171, 857-863.
119. Domingues, R.; Lakeman, F.; Pannuti, C.; Fink, M.; Tsanaclis, A. Advantage of polymerase chain reaction in the diagnosis of herpes simplex encephalitis: presentation of 5 atypical cases. Scand. J. Infect. Dis., 1997, 29, 229-31.
120. Taylor, S.; Lee, D.; Jackson, A. Herpes simplex encephalitis presenting with exclusively frontal lobe involvement. J. Neurovirol., 2007, 13, 477-481.
121. Chu, K.; Kang, D.; Lee, J.; Yoon, B. Atypical brainstem encephalitis caused by herpes simplex virus 2. Arch. Neurol., 2002, 59, 460-463.
122. Whitley, R.; Cobbs, C.; Alford, C. J.; Soong, S.; Hirsch, M.; Connor, J.; Corey, L.; Hanley, D.; Levin, M.; Powell, D. Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. J.A.M.A., 1989, 262, 234-239.
123. Gaeta, A.; Verzaro, S.; Cristina, L.; Mancini, C.; Nazzari, C. Diagnosis of neurological herpesvirus infections: real time PCR in cerebral spinal fluid analysis. New Microbiol., 2009, 32, 333-340.
124. Wiedbrauk, D. L.; Cunningham, W. Stability of herpes simplex virus DNA in cerebrospinal fluid specimens. Diagn. Mol.Pathol., 1996, 5, 249-252.
125. Rotbart, H. A.; Levin, M. J.; Villarreal, L. P.; Tracy, S. M.; Semler, B. L.; Wimmer, E. Factors affecting the detection of enteroviruses in cerebrospinal fluid with coxsackievirus B3 and poliovirus 1 cDNA probes. J. Clin. Microbiol., 1985, 22, 220-224.
126. Singer, E. J.; Aronow, H. A.; Lee, S. Y.; Hinkin, C. H.; Lazarus, T. Stability of human immunodeficiency virus type 1 RNA in cerebrospinal fluid determined with the AMPLICOR HIV-1 MONITOR test, version 1.5 (ultrasensitive). J. Clin. Microbiol., 2002, 40, 3863-3864.
127. Ahmad, M.; Tashima, K. T.; Caliendo, A. M.; Flanigan, T. P. Cerebrospinal fluid and plasma HIV-1 RNA stability at 4 degrees C. AIDS, 1999, 13, 1281-1282.
128. Ginocchio, C. C.; Wang, X. P.; Kaplan, M. H.; Mulligan, G.; Witt, D.; Romano, J. W.; Cronin, M.; Carroll, R. Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma. J. Clin. Microbiol., 1997, 35, 2886-2893.
129. Saiki, R.; Gelfand, D.; Stoffel, S.; Scharf, S.; Higuchi, R.; Horn, G.; Mullis, K.; Erlich, H. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 1988, 239, 487-491.
130. Rowley, A.; Whitley, R.; Lakeman, F.; Wolinsky, S. Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet, 1990, 335 (8687), 440-441.
131. LePecq, J.; Paoletti, C. A fluorescent complex between ethidium bromide and nucleic acids. Physical-chemical characterization. J.Mol.Biol., 1967, 27, 87-106.
132. Fox, J.; Griffiths, P.; Emery, V. Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J.Gen.Virol., 1992, 73, 2405-2408.
133. Bruisten, S.; Koppelman, M.; Roos, M.; Loeliger, A.; Reiss, P.; Boucher, C.; Huisman, H. Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments. AIDS 1993, 7 (Suppl 2), S15- S20.
134. Kidd, I.; Clark, D.; Emery, V. A non-radioisotopic quantitative competitive polymerase chain reaction method: application in measurement of human herpesvirus 7 load. J. Virol. Methods, 2000, 87, 177-181.
135. Myers, T.; Gelfand, D. Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry, 1991, 30, 7661-7666.
136. Klein, D. Quantification using real-time PCR technology: applications and limitations. Trends in Molecular Medicine 2002, 8, 257-260.
137. Holland, P.; Abramson, R.; Watson, R.; Gelfand, D. Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA, 1991, 88, 7276-7280.
138. nd ed.; Dieffenbach, C. W.; Dveksler, G. S., Eds. CSHL Press: Cold Spring Harbor, NY, 2003; pp 61-74.
139. Espy, M.; Uhl, J.; Mitchell, P.; Thorvilson, J.; Svien, K.; Wold, A.; Smith, T. Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR. J. Clin. Microbiol., 2000, 38, 795-799.
140. Schalasta, G.; Arents, A.; Schmid, M.; Braun, R.; Enders, G. Fast and type-specific analysis of herpes simplex virus types 1 and 2 by rapid PCR and fluorescence melting-curve-analysis. Infection, 2000, 28, 85-91.
141. Whiley, D. M.; Mackay, I. M.; Syrmis, M. W.; Witt, M. J.; Sloots, T. P. Detection and differentiation of herpes simplex virus types 1 and 2 by a duplex LightCycler PCR that incorporates an internal control PCR reaction. J. Clin. Virol., 2004, 30, 32-38.
142. Whiley, D.; Syrmis, M.; Mackay, I.; Sloots, T. Preliminary comparison of three Light Cycler PCR assays for the detection of herpes simplex virus in swab specimens. Eur J. Clin. Microbiol. Infect. Dis., 2003, 22, 764-767.
143. Bustin, S. A.; Nolan, T. Chemistries. In: A-Z of Quantitative PCR, Bustin, S. A., Ed. International University Line: La Jolla, CA, 2004; pp 217-278.
144. Waltz, T. L.; Marras, S.; Rochford, G.; Nolan, J.; Lee, E.; Melegari, M.; Pollack, H. Development of a molecular-beacon assay to detect the G1896A precore mutation in hepatitis B virus-infected individuals. J. Clin. Microbiol., 2005, 43, 254-258.
145. Yeo, A. C.; Chan, K. P.; Kumarasinghe, G.; Yap, H. K. Rapid detection of codon 460 mutations in the UL97 gene of ganciclovir-resistant cytomegalovirus clinical isolates by real-time PCR using molecular beacons. Mol. Cell Probes, 2005, 19, 389-393.
146. Bustin, S.; Nolan, T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J.Biomolec.Technol., 2004, 15, 155-166.
147. Beloukas, A.; Paraskevis, D.; Haida, C.; Sypsa, V.; Hatzakis, A., Development and assessment of a multiplex real-time PCR assay for quantification of human immunodeficiency virus type 1 DNA. J. Clin. Microbiol., 2009, 47, 2194-2199.
148. Morandi, L.; Ferrari, D.; Lombardo, C.; Pession, A.; Tallini, G. Monitoring HCV RNA viral load by locked nucleic acid molecular beacons real time PCR. J. Virol.Methods, 2007, 140, 148-154.
149. Takacs, T.; Jeney, C.; Kovacs, L.; Mozes, J.; Benczik, M.; Sebe, A. Molecular beacon-based real-time PCR method for detection of 15 high-risk and 5 low-risk HPV types. J. Virol.Methods, 2008, 149 (1), 153-162.
150. Moore, C.; Valappil, M.; Corden, S.; Westmoreland, D. Enhanced clinical utility of the NucliSens EasyQ RSV A+B Assay for rapid detection of respiratory syncytial virus in clinical samples. Eur. J. Clin. Microbiol. Infect. Dis., 2006, 25, 167-174.
151. Thelwell, N.; Millington, S.; Solinas, A.; Booth, J.; Brown, T. Mode of action and application of Scorpion primers to mutation detection. Nucleic Acids Res., 2000, 28, 3752-3761.
152. Kumar, R.; Singh, S. K.; Koshkin, A. A.; Rajwanshi, V. K.; Meldgaard, M.; Wengel, J. The first analogues of LNA (locked nucleic acids): phosphorothioate-LNA and 2'-thio-LNA. Bioorg. Med.Chem. Lett., 1998, 8, 2219-2222.
153. Koshkin, A. A.; Singh, S. K.; Nielsen, P.; Rajwanshi, V. K.; Kumar, R.; Meldgaard, M.; Olsen, C. E.; Wengel, J. LNA (Locked Nucleic Acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers,oligomerisation, and unprecedented nucleic acid recognition. Tetrahedron, 1998, 54, 3607-3630.
154. Plourde, P. J.; Mphuka, S.; Muyinda, G. K.; Banda, M.; Sichali-Sichinga, K.; Chama, D.; Ronald, A. R. Accuracy and costs of rapid human immunodeficiency virus testing technologies in rural hospitals in Zambia. Sex.Transm. Dis., 1998, 254-259.
155. Ugozzoli, L. A.; Latorra, D.; Puckett, R.; Arar, K.; Hamby, K. Real-time genotyping with oligonucleotide probes containing locked nucleic acids. Anal. Biochem., 2004, 324, 143-152.
156. Mouritzen, P.; Nielsen, A. T.; Pfundheller, H. M.; Choleva, Y.; Kongsbak, L.; Moller, S. Single nucleotide polymorphism genotyping using locked nucleic acid (LNA). Expert Rev. Mol. Diagn., 2003, 3, 27-38.
157. Corless, C.; Guiver, M.; Borrow, R.; Edwards-Jones, V.; Fox, A.; Kaczmarski, E. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J.Clin.Microbiol., 2001, 39, 1553-1558.
158. Jackson, R.; Morris, D.; Cooper, R.; Bailey, A.; Klapper, P.; Cleator, G.; Tullo, A. Multiplex polymerase chain reaction for adenovirus and herpes simplex virus in eye swabs. J. Virol. Methods, 1996, 56, 41-48.
159. Elnifro, E.; Cooper, R.; Klapper, P.; Yeo, A.; Tullo, A. Multiplex polymerase chain reaction for diagnosis of viral and chlamydial keratoconjunctivitis. Invest. Ophthalmol.Vis. Sci., 2000, 41, 1818-1822.
160. Syrmis, M.; Whiley, D.; Thomas, M.; Mackay, I.; Williamson, J.; Siebert, D.; Nissen, M.; Sloots, T. A sensitive, specific, and cost-effective multiplex reverse transcriptase-PCR assay for the detection of seven common respiratory viruses in respiratory samples. J. Molec. Diag.,2004, 6, 125-131.
161. Bellau-Pujol, S.; Vabret, A.; Legrand, L.; Dina, J.; Gouarin, S.; Petitjean-Lecherbonnier, J.; Pozzetto, B.; Ginevra, C.; Freymuth, F. Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses. J. Virol.Methods, 2005, 126, 53-63.
162. Brittain-Long, R.; Westin, J.; Olofsson, S.; Lindh, M.; Andersson, L. M. Prospective evaluation of a novel multiplex real-time PCR assay for detection of fifteen respiratory pathogens-Duration of symptoms significantly affects detection rate. J.Clin.Virol., 2010, 47, 263-267.
163. Gunson, R.; Bennett, S.; Maclean, A.; Carman, W. Using multiplex real time PCR in order to streamline a routine diagnostic service. J. Clin.Virol., 2008, 43, 372-375.
164. Gunson, R.; Collins, T.; Carman, W. Practical experience of high throughput real time PCR in the routine diagnostic virology setting. J. Clin.Virol., 2006, 35, 355-367.
165. Boriskin, Y. S.; Rice, P. S.; Stabler, R. A.; Hinds, J.; Al-Ghusein, H.; Vass, K.; Butcher, P. D. DNA microarrays for virus detection in cases of central nervous system infection. J. Clin. Microbiol., 2004, 42, 5811-5818.
166. Elnifro, E.; Ashshi, A.; Cooper, R.; Klapper, P. Multiplex PCR: optimization and application in diagnostic virology. Clin. Microbiol. Rev., 2000, 13, 559-570.
167. Read, S. J.; Kurtz, J. B. Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J. Clin. Microbiol., 1999, 37, 1352-1355.
168. Colimon, R.; Minjolle, S.; Andre, P.; de la Pintiere, C. T.; Ruffault, A.; Michelet, C.; Cartier, F. New types of primers (stair primers) for PCR amplification of the variable V3 region of the human immunodeficiency virus. J. Virol. Methods, 1996, 58, 7-19.
169. Minjolle, S.; Michelet, C.; Jusselin, I.; Joannes, M.; Cartier, F.; Colimon, R., Amplification of the six major human herpesviruses from cerebrospinal fluid by a single PCR. J. Clin. Microbiol., 1999, 37, 950-953.
170. Minjolle, S.; Arvieux, C.; Gautier, A. L.; Jusselin, I.; Thomas, R.; Michelet, C.; Colimon, R., Detection of herpesvirus genomes by polymerase chain reaction in cerebrospinal fluid and clinical findings. J.Clin.Virol., 2002, 25 (Suppl 1), S59-S70.
171. Calvario, A.; Bozzi, A.; Scarasciulli, M.; Ventola, C.; Seccia, R.; Stomati, D.; Brancasi, B., Herpes Consensus PCR test: a useful diagnostic approach to the screening of viral diseases of the central nervous system. J.Clin.Virol., 2002, 25(Suppl 1), S71-8.
172. Gibson, U. E.; Heid, C. A.; Williams, P. M. A novel method for real time quantitative RT-PCR. Genome. Res., 1996, 6, 995-1001.
173. Raeymaekers, L. Basic principles of quantitative PCR. Mol. Biotechnol., 2000, 15, 115-122.
174. Zipper, H.; Brunner, H.; Bernhagen, J.; Vitzthum, F. Investigations on DNA intercalation and surface binding by SYBR Green I, its structure determination and methodological implications. Nucleic Acids Res., 2004, 32, e103.
175. Nahmias, A.; Whitley, R.; Visintine, A.; Takei, Y.; Alford, C. J. Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J.Infect.Dis., 1982, 145, 829-836.
176. Revello, M. G.; Baldanti, F.; Sarasini, A.; Zella, D.; Zavattoni, M.; Gerna, G. Quantitation of herpes simplex virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis by the polymerase chain reaction. Clin. Diagn. Virol., 1997, 7, 183-191.
177. Hjalmarsson, A.; Granath, F.; Forsgren, M.; Brytting, M.; Blomqvist, P.; Sköldenberg, B. Prognostic value of intrathecal antibody production and DNA viral load in cerebrospinal fluid of patients with herpes simplex encephalitis. J. Neurol., 2009, 256, 1243-1251.
178. Kamei, S.; Takasu, T.; Morishima, T.; Mizutani, T. Serial changes of intrathecal viral loads evaluated by chemiluminescence assay and nested PCR with aciclovir treatment in herpes simplex virus encephalitis. Intern. Med., 2004, 43, 796-801.
179. Schloss, L.; Falk, K. I.; Skoog, E.; Brytting, M.; Linde, A.; Aurelius, E. Monitoring of herpes simplex virus DNA types 1 and 2 viral load in cerebrospinal fluid by real-time PCR in patients with herpes simplex encephalitis. J. Med. Virol., 2009, 81, 1432-1437.
180. Aurelius, E.; Forsgren, M.; Sköldenberg, B.; Strannegård, O. Persistent intrathecal immune activation in patients with herpes simplex encephalitis. J. Infect. Dis., 1993, 168, 1248-1252.
181. Meyding-Lamade, U.; Lamade, W.; Kehm, R.; Oberlinner, C.; Fath, A.; Wildemann, B.; Haas, J.; Hacke, W. Herpes simplex virus encephalitis: chronic progressive cerebral MRI changes despite good clinical recovery and low viral load-an experimental mouse study. Eur. J. Neurol., 1999, 6, 531-538.
182. Stingele, K.; Haas, J.; Zimmermann, T.; Stingele, R.; Hubsch-Muller, C.; Freitag, M.; Storch-Hagenlocher, B.; Hartmann, M.; Wildemann, B. Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy. Neurology, 2001, 56, 355-361.
183. McClernon, D. R.; Lanier, R.; Gartner, S.; Feaser, P.; Pardo, C. A.; St Clair, M.; Liao, Q.; McArthur, J. C. HIV in the brain: RNA levels and patterns of zidovudine resistance. Neurology, 2001, 57, 1396-1401.
184. Bossolasco, S.; Calori, G.; Moretti, F.; Boschini, A.; Bertelli, D.; Mena, M.; Gerevini, S.; Bestetti, A.; Pedale, R.; Sala, S.; Lazzarin, A.; Cinque, P. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin.Infect.Dis., 2005, 40, 738-744.
185. Dieffenbach, C.; Lowe, T.; Dveksler, G. General concepts for PCR primer design. PCR Methods Appl., 1993, 3, S30-S37.
186. Wacharapluesadee, S.; Sutipanya, J.; Damrongwatanapokin, S.; Phumesin, P.; Chamnanpood, P.; Leowijuk, C.; Hemachudha, T. Development of a Taq Man real-time RT-PCR assay for the detection of rabies virus. J. Virol.Methods, 2008, 151, 317-320.
187. Hughes, G. J.; Smith, J. S.; Hanlon, C. A.; Rupprecht, C. E. Evaluation of a Taq Man PCR assay to detect rabies virus RNA: influence of sequence variation and application to quantification of viral loads. J. Clin. Microbiol., 2004, 42, 299-306.
188. Hoffmann, B.; Freuling, C. M.; Wakeley, P. R.; Rasmussen, T. B.; Leech, S.; Fooks, A. R.; Beer, M.; Müller, T. Improved safety for molecular diagnosis of classical rabies viruses by use of a TaqMan real-time reverse transcription-PCR double check strategy. J. Clin. Microbiol., 2010, 48, 3970-3978.
189. Kim, Y. H.; Yang, I.; Bae, Y. S.; Park, S. R. Performance evaluation of thermal cyclers for PCR in a rapid cycling condition. Biotechniques, 2008, 44, 495-496.
190. Beutler, E.; Gelbart, T.; Kuhl, W. Interference of heparin with the polymerase chain reaction. Biotechniques, 1990, 9, 166.
191. Pardoe, I.; Michalak, T. Detection of hepatitis B and woodchuck hepatitis viral DNA in plasma and mononuclear cells from heparinized blood by the polymerase chain reaction. J.Virol.Methods, 1995, 51, 277-288.
192. Furukawa, K.; Bhavanandan, V. Influences of anionic polysaccharides on DNA synthesis in isolated nuclei and by DNA polymerase alpha: correlation of observed effects with properties of the polysaccharides. Biochim. Biophys. Acta, 1983, 740, 466-475.
193. Tami, C.; Puig, M.; Reepmeyer, J.; Ye, H.; D'Avignon, D.; Buhse, L.; Verthelyi, D. Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants. Biomaterials, 2008, 29, 4808-4814.
194. Huggett, J.; Novak, T.; Garson, J.; Green, C.; Morris-Jones, S.; Miller, R.; Zumla, A., Differential susceptibility of PCR reactions to inhibitors: an important and unrecognised phenomenon. BMC Res. Notes, 2008, 1, 70.
195. Dennett, C.; Klapper, P.; Cleator, G.; Lewis, A. CSF pretreatment and the diagnosis of herpes encephalitis using the polymerase chain reaction. J.Virol. Methods,1991, 34, 101-104.
196. Al-Soud, W.; Jönsson, L.; Râdström, P. Identification and characterization of immunoglobulin G in blood as a major inhibitor of diagnostic PCR. J. Clin. Microbiol., 2000, 38 (1), 345-350.
197. Kermekchiev, M. B.; Kirilova, L. I.; Vail, E. E.; Barnes, W. M. Mutants of Taq DNA polymerase resistant to PCR inhibitors allow DNA amplification from whole blood and crude soil samples. Nucleic Acids Res., 2009, 37, e40.
198. Bustin, S. A.; Benes, V.; Garson, J. A.; Hellemans, J.; Huggett, J.; Kubista, M.; Mueller, R.; Nolan, T.; Pfaffl, M. W.; Shipley, G. L.; Vandesompele, J.; Wittwer, C. T. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin.Chem., 2009, 55, 611-622.
199. Persing, D. Polymerase chain reaction: trenches to benches. J. Clin. Microbiol., 1991, 29, 1281-1285.
200. Ellis, J. S.; Smith, J. W.; Braham, S.; Lock, M.; Barlow, K.; Zambon, M. C. Design and validation of an H5 TaqMan real-time one-step reverse transcription-PCR and confirmatory assays for diagnosis and verification of influenza A virus H5 infections in humans. J. Clin. Microbiol., 2007, 45, 1535-1543.
201. Yang, S.; Rothman, R. E. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect. Dis., 2004, 4, 337-348.
202. Ellison, S.; English, C.; Burns, M.; Keer, J. Routes to improving the reliability of low level DNA analysis using real-time PCR. BMC Biotechnol., 2006, 6, 33.
203. Deshpande, A.; Gans, J.; Graves, S.; Green, L.; Taylor, L.; Kim, H.; Kunde, Y.; Leonard, P.; Li, P.; Mark, J.; Song, J.; Vuyisich, M.; White, P. A rapid multiplex assay for nucleic acid-based diagnostics. J. Microbiol. Methods, 2010, 80, 155-163.
204. Hromadnikova, I.; Houbova, B.; Hridelova, D.; Voslarova, S.; Kofer, J.; Komrska, V.; Habart, D. Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of non-invasive fetal sex determination. Prenat Diagn, 2003, 23, 235-238.
205. Dagan, R.; Shriker, O.; Hazan, I.; Leibovitz, E.; Greenberg, D.; Schlaeffer, F.; Levy, R. Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR. J.Clin. Microbiol., 1998, 36, 669-673.
206. Salo, P.; Ortqvist, A.; Leinonen, M. Diagnosis of bacteremic pneumococcal pneumonia by amplification of pneumolysin gene fragment in serum. J. Infect. Dis., 1995, 171, 479-482.
207. Cohrs, R.; Gilden, D. Human herpesvirus latency. Brain Pathol., 2001, 11, 465-474.
208. De Bolle, L.; Naesens, L.; De Clercq, E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin. Microbiol. Rev., 2005, 18, 217-245
209. Ward, K.; Leong, H.; Thiruchelvam, A.; Atkinson, C.; Clark, D. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J. Clin. Microbiol., 2007, 45, 1298-1304.
210. Clark, D.; Ward, K. Importance of chromosomally integrated HHV-6A and -6B in the diagnosis of active HHV-6 infection. Herpes, 2008, 15, 28-32.
211. Nacheva, E. P.; Ward, K. N.; Brazma, D.; Virgili, A.; Howard, J.; Leong, H. N.; Clark, D. A. Human herpesvirus 6 integrates within telomeric regions as evidenced by five different chromosomal sites. J. Med. Virol., 2008, 80, 1952-1958.
212. Fotheringham, J.; Akhyani, N.; Vortmeyer, A.; Donati, D.; Williams, E.; Oh, U.; Bishop, M.; Barrett, J.; Gea-Banacloche, J.; Jacobson, S. Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid. J. Infect. Dis., 2007, 195, 450-454.
213. Laina, I.; Syriopoulou, V.; Daikos, G.; Roma, E.; Papageorgiou, F.; Kakourou, T.; Theodoridou, M. Febrile seizures and primary human herpesvirus 6 infection. Pediatric Neurol., 2010, 42, 28-31.
214. Ward, K. N.; Leong, H. N.; Thiruchelvam, A. D.; Atkinson, C. E.; Clark, D. A. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J. Clin. Microbiol., 2007, 45, 1298-1304.
215. Persson, A.; Bergstrom, T.; Lindh, M.; Namvar, L.; Studahl, M. Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels. J.Clin. Virol., 2009, 46, 249-253.
216. Sonza, S.; Mutimer, H.; Oelrichs, R.; Jardine, D.; Harvey, K.; Dunne, A.; Purcell, D.; Birch, C.; Crowe, S. Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS, 2001, 15, 17-22.
217. Wong, J.; Hezareh, M.; Gunthard, H.; Havlir, D.; Ignacio, C.; Spina, C.; Richman, D. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science, 1997, 278, 1291-1295.
218. Decker, L.; Klaman, L.; Thorley-Lawson, D. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J. Virol., 1996, 70, 3286-3289.
219. Boom, R.; Sol, C. J.; Salimans, M. M.; Jansen, C. L.; Wertheim-van Dillen, P. M.; van der Noordaa, J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol., 1990, 28, 495-503.
220. Schuurman, T.; van Breda, A.; de Boer, R.; Kooistra-Smid, M.; Beld, M.; Savelkoul, P.; Boom, R. Reduced PCR sensitivity due to impaired DNA recovery with the MagNA Pure LC total nucleic acid isolation kit. J. Clin. Microbiol., 2005, 43, 4616-4622.
221. Riemann, K.; Adamzik, M.; Frauenrath, S.; Egensperger, R.; Schmid, K. W.; Brockmeyer, N. H.; Siffert, W. Comparison of manual and automated nucleic acid extraction from whole-blood samples. J. Clin. Lab. Anal., 2007, 21, 244-248.
222. Tebas, P.; Nease, R. F.; Storch, G. A. Use of the polymerase chain reaction in the diagnosis of herpes simplex encephalitis: a decision analysis model. Am. J. Med.,1998, 105, 287-295.
223. Weil, A. A.; Glaser, C. A.; Amad, Z.; Forghani, B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin. Infect.Dis., 2002, 34, 1154-1157.
224. De Tiege, X.; Heron, B.; Lebon, P.; Ponsot, G.; Rozenberg, F. Limits of early diagnosis of herpes simplex encephalitis in children: a retrospective study of 38 cases. Clin. Infect. Dis., 2003, 36, 1335-1339.
225. Cinque, P.; Cleator, G. M.; Weber, T.; Monteyne, P.; Sindic, C. J.; van Loon, A. M. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis. J. Neurol. Neurosurg. Psychiatry, 1996, 61, 339-345.
226. Gracias, K. S.; McKillip, J. L. Nucleic acid sequence-based amplification (NASBA) in molecular bacteriology: a procedural guide. J. Rapid Methods Automation Microbiol., 2007, 15, 295-309.
227. Compton, J. Nucleic acid sequence-based amplification. Nature, 1991, 350 (6313), 91-92.
228. Heim, A.; Schumann, J. Development and evaluation of a nucleic acid sequence based amplification (NASBA) protocol for the detection of enterovirus RNA in cerebrospinal fluid samples. J. Virol.Methods, 2002, 103, 101-107.
229. Rotbart, H. A.; Sawyer, M. H.; Fast, S.; Lewinski, C.; Murphy, N.; Keyser, E. F.; Spadoro, J.; Kao, S. Y.; Loeffelholz, M. Diagnosis of enteroviral meningitis by using PCR with a colorimetric microwell detection assay. J. Clin. Microbiol., 1994, 32, 2590-2592.
230. Rotbart, H. A. Reproducibility of AMPLICOR enterovirus PCR test results. J. Clin. Microbiol., 1997, 35, 3301-3302.
231. Wu, S. J.; Lee, E. M.; Putvatana, R.; Shurtliff, R. N.; Porter, K. R.; Suharyono, W.; Watts, D. M.; King, C. C.; Murphy, G. S.; Hayes, C. G.; Romano, J. W. Detection of dengue viral RNA using a nucleic acid sequence-based amplification assay. J. Clin. Microbiol., 2001, 39, 2794-2798.
232. Lanciotti, R. S. Molecular amplification assays for the detection of flaviviruses. Adv. Virus. Res., 2003, 61, 67-99.
233. Lambert, A. J.; Nasci, R. S.; Cropp, B. C.; Martin, D. A.; Rose, B. C.; Russell, B. J.; Lanciotti, R. S. Nucleic acid amplification assays for detection of La Crosse virus RNA. J. Clin. Microbiol., 2005, 43, 1885-1889.
234. Deiman, B.; Jay, C.; Zintilini, C.; Vermeer, S.; van Strijp, D.; Venema, F.; van de Wiel, P. Efficient amplification with NASBA of hepatitis B virus, herpes simplex virus and methicillin resistant Staphylococcus aureus DNA. J. Virol. Methods, 2008, 151, 283-293.
235. Cook, R. L.; Hutchison, S. L.; Ostergaard, L.; Braithwaite, R. S.; Ness, R. B., Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann. Intern. Med., 2005, 142, 914-925.
236. Nye, M. B.; Schwebke, J. R.; Body, B. A. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am. J. Obstet. Gynecol., 2009, 200, 188 e1-7.
237. Morishima, C.; Morgan, T. R.; Everhart, J. E.; Wright, E. C.; Apodaca, M. C.; Gretch, D. R.; Shiffman, M. L.; Everson, G. T.; Lindsay, K. L.; Lee, W. M.; Lok, A. S.; Dienstag, J. L.; Ghany, M. G.; Curto, T. M. Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C. Hepatology, 2008, 48, 1412-1419.
238. Little, M. C.; Andrews, J.; Moore, R.; Bustos, S.; Jones, L.; Embres, C.; Durmowicz, G.; Harris, J.; Berger, D.; Yanson, K.; Rostkowski, C.; Yursis, D.; Price, J.; Fort, T.; Walters, A.; Collis, M.; Llorin, O.; Wood, J.; Failing, F.; O'Keefe, C.; Scrivens, B.; Pope, B.; Hansen, T.; Marino, K.; Williams, K. Strand displacement amplification and homogeneous real-time detection incorporated in a second-generation DNA probe system, BDProbeTecET. Clin.Chem., 1999, 45, 777-784.
239. Parida, M.; Sannarangaiah, S.; Dash, P. K.; Rao, P. V.; Morita, K. Loop mediated isothermal amplification (LAMP): a new generation of innovative gene amplification technique; perspectives in clinical diagnosis of infectious diseases. Rev. Med. Virol., 2008, 18, 407-421.
240. Mori, Y.; Notomi, T. Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases. J. Infect. Chemother., 2009, 15, 62-69.
241. Loy, A.; Bodrossy, L. Highly parallel microbial diagnostics using oligonucleotide microarrays. Clin. Chim. Acta, 2006, 363, 106-119.
242. Mikhailovich, V.; Gryadunov, D.; Kolchinsky, A.; Makarov, A. A.; Zasedatelev, A. DNA microarrays in the clinic: infectious diseases. Bioessays, 2008, 30, 673-682.
243. Muller, R.; Ditzen, A.; Hille, K.; Stichling, M.; Ehricht, R.; Illmer, T.; Ehninger, G.; Rohayem, J. Detection of herpesvirus and adenovirus co-infections with diagnostic DNA-microarrays. J. Virol. Methods, 2009, 155, 161-166.
244. Frobert, E.; Escuret, V.; Javouhey, E.; Casalegno, J. S.; Bouscambert-Duchamp, M.; Moulinier, C.; Gillet, Y.; Lina, B.; Floret, D.; Morfin, F. Respiratory viruses in children admitted to hospital intensive care units: Evaluating the CLART(R) Pneumovir DNA array. J. Med. Virol., 2011, 83, 150-155.
245. Shi, J.; Wu, Y.; Cai, M.; Shang, S. Rapid diagnosis of herpetic encephalitis in children by PCR-microarray technology for simultaneous detection of seven human herpes viruses. Eur. J.Pediatr., 2010, 169, 421-425.
246. Korimbocus, J.; Scaramozzino, N.; Lacroix, B.; Crance, J. M.; Garin, D.; Vernet, G. DNA probe array for the simultaneous identification of herpesviruses, enteroviruses, and flaviviruses. J. Clin. Microbiol., 2005, 43, 3779-3787.
247. Abruzzo, L. V.; Lee, K. Y.; Fuller, A.; Silverman, A.; Keating, M. J.; Medeiros, L. J.; Coombes, K. R. Validation of oligonucleotide microarray data using microfluidic low-density arrays: a new statistical method to normalize real-time RT-PCR data. Biotechniques, 2005, 38, 785-792.
248. Fink, J.; Gu, F.; Ling, L.; Tolfvenstam, T.; Olfat, F.; Chin, K. C.; Aw, P.; George, J.; Kuznetsov, V. A.; Schreiber, M.; Vasudevan, S. G.; Hibberd, M. L. Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl. Trop. Dis., 2007, 1, e86.
249. Spits, C.; Le Caignec, C.; De Rycke, M.; Van Haute, L.; Van Steirteghem, A.; Liebaers, I.; Sermon, K. Whole-genome multiple displacement amplification from single cells. Nat.Protoc., 2006, 1, 1965-1970.
250. Berthet, N.; Reinhardt, A. K.; Leclercq, I.; van Ooyen, S.; Batejat, C.; Dickinson, P.; Stamboliyska, R.; Old, I. G.; Kong, K. A.; Dacheux, L.; Bourhy, H.; Kennedy, G. C.; Korfhage, C.; Cole, S. T.; Manuguerra, J. C. Phi29 polymerase based random amplification of viral RNA as an alternative to random RT-PCR. BMC Mol. Biol., 2008, 9, 77.
251. Tissari, P.; Zumla, A.; Tarkka, E.; Mero, S.; Savolainen, L.; Vaara, M.; Aittakorpi, A.; Laakso, S.; Lindfors, M.; Piiparinen, H.; Maki, M.; Carder, C.; Huggett, J.; Gant, V. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet, 2010, 375 (9710), 224-230.
252. A DNA-based microarray platform: an observational study. Lancet, 2010, 375 (9710), 224-230.
253. Jarvinen, A. K.; Laakso, S.; Piiparinen, P.; Aittakorpi, A.; Lindfors, M.; Huopaniemi, L.; Piiparinen, H.; Maki, M. Rapid identification of bacterial pathogens using a PCR- and microarray-based assay. BMC Microbiol., 2009, 9, 161.
254. Zhu, L. X.; Zhang, Z. W.; Liang, D.; Jiang, D.; Wang, C.; Du, N.; Zhang, Q.; Mitchelson, K.; Cheng, J. Multiplex asymmetric PCR-based oligonucleotide microarray for detection of drug resistance genes containing single mutations in Enterobacteriaceae. Antimicrob. Agents Chemother., 2007, 51, 3707-3713.
255. Vasiliskov, V. A.; Chudinov, A. V.; Chechetkin, V. R.; Surzhikov, S. A.; Zasedatelev, A. S.; Mikhailovich, V. M. Separate production of single-stranded DNA is not necessary: circuit denaturation of double-stranded DNA followed by hybridization of single strands on oligonucleotide microchips. J. Biomol. Struct. Dyn., 2009, 27, 347-360.
256. Kim, K. T.; Na, C. H.; Yun, Y. M.; Hwang, T. S.; Kim, S. N.; Chae, C. B. Dramatic increase in signal by integration of polymerase chain reaction and hybridization on surface of DNA microarray. Anal. Biochem., 2010, 396, 139-145.
257. Wang, Z.; Malanoski, A. P.; Lin, B.; Kidd, C.; Long, N. C.; Blaney, K. M.; Thach, D. C.; Tibbetts, C.; Stenger, D. A. Resequencing microarray probe design for typing genetically diverse viruses: human rhinoviruses and enteroviruses. BMC Genomics, 2008, 9, 577.
258. Corless, C. E.; Kaczmarski, E.; Borrow, R.; Guiver, M. Molecular characterization of Neisseria meningitidis isolates using a resequencing DNA microarray. J. Mol. Diagn., 2008, 10, 265-271.
259. Berthet, N.; Dickinson, P.; Filliol, I.; Reinhardt, A.; Batejat, C.; Vallaeys, T.; Kong, K.; Davies, C.; Lee, W.; Zhang, S.; Turpaz, Y.; Heym, B.; Coralie, G.; Dacheux, L.; Burguière, A.; Bourhy, H.; Old, I.; Manuguerra, J.-C.; Cole, S.; Kennedy, G. Massively parallel pathogen identification using high-density microarrays. Microbial. Biotechnol., 2008, 1, 79-86.
260. Dacheux, L.; Berthet, N.; Dissard, G.; Holmes, E. C.; Delmas, O.; Larrous, F.; Guigon, G.; Dickinson, P.; Faye, O.; Sall, A. A.; Old, I. G.; Kong, K.; Kennedy, G. C.; Manuguerra, J. C.; Cole, S. T.; Caro, V.; Gessain, A.; Bourhy, H. Application of broad-spectrum resequencing microarray for genotyping rhabdoviruses. J. Virol., 2010, 84, 9557-9574.
261. Metzgar, D.; Myers, C. A.; Russell, K. L.; Faix, D.; Blair, P. J.; Brown, J.; Vo, S.; Swayne, D. E.; Thomas, C.; Stenger, D. A.; Lin, B.; Malanoski, A. P.; Wang, Z.; Blaney, K. M.; Long, N. C.; Schnur, J. M.; Saad, M. D.; Borsuk, L. A.; Lichanska, A. M.; Lorence, M. C.; Weslowski, B.; Schafer, K. O.; Tibbetts, C. Single assay for simultaneous detection and differential identification of human and avian influenza virus types, subtypes, and emergent variants. PLoS One 2010, 5, e8995.
262. Quan, P. L.; Palacios, G.; Jabado, O. J.; Conlan, S.; Hirschberg, D. L.; Pozo, F.; Jack, P. J.; Cisterna, D.; Renwick, N.; Hui, J.; Drysdale, A.; Amos-Ritchie, R.; Baumeister, E.; Savy, V.; Lager, K. M.; Richt, J. A.; Boyle, D. B.; Garcia-Sastre, A.; Casas, I.; Perez-Brena, P.; Briese, T.; Lipkin, W. I. Detection of respiratory viruses and subtype identification of influenza A viruses by GreeneChipResp oligonucleotide microarray. J. Clin. Microbiol., 2007, 45, 2359-2364.
263. Wang, D.; Coscoy, L.; Zylberberg, M.; Avila, P. C.; Boushey, H. A.; Ganem, D.; DeRisi, J. L. Microarray-based detection and genotyping of viral pathogens. Proc. Natl. Acad. Sci. USA, 2002, 99, 15687-15692.
264. Gurrala, R.; Dastjerdi, A.; Johnson, N.; Nunez-Garcia, J.; Grierson, S.; Steinbach, F.; Banks, M. Development of a DNA microarray for simultaneous detection and genotyping of lyssaviruses. Virus. Res., 2009, 144, 202-208.
265. Dunbar, S. Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin. Chimica. Acta, 2006, 363, 71-82.
266. Rao, R. S.; Visuri, S. R.; McBride, M. T.; Albala, J. S.; Matthews, D. L.; Coleman, M. A. Comparison of multiplexed techniques for detection of bacterial and viral proteins. J. Proteome Res., 2004, 3, 736-742.
267. Mahony, J.; Chong, S.; Merante, F.; Yaghoubian, S.; Sinha, T.; Lisle, C.; Janeczko, R. Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay. J. Clin. Microbiol., 2007, 45, 2965-2970.
268. Pabbaraju, K.; Tokaryk, K. L.; Wong, S.; Fox, J. D. Comparison of the Luminex xTAG respiratory viral panel with in-house nucleic acid amplification tests for diagnosis of respiratory virus infections. J. Clin. Microbiol., 2008, 46, 3056-3062.
269. Nolte, F. S.; Marshall, D. J.; Rasberry, C.; Schievelbein, S.; Banks, G. G.; Storch, G. A.; Arens, M. Q.; Buller, R. S.; Prudent, J. R. MultiCode-PLx system for multiplexed detection of seventeen respiratory viruses. J. Clin. Microbiol., 2007, 45, 2779-2786.
270. Boving, M. K.; Pedersen, L. N.; Moller, J. K. Eight-plex PCR and liquid-array detection of bacterial and viral pathogens in cerebrospinal fluid from patients with suspected meningitis. J. Clin. Microbiol., 2009, 47, 908-913.
271. Fuchs, B.; Süß, R.; Nimptsch, A.; Schiller, J. MALDI-TOF-MS directly combined with TLC: a review of the current state. Chromatographia, 2009, 69 (Supplement), S95-S105.
272. Soderlund-Strand, A.; Dillner, J.; Carlson, J. High-throughput genotyping of oncogenic human papilloma viruses with MALDI-TOF mass spectrometry. Clin.Chem., 2008, 54, 86-92.
273. Luan, J.; Yuan, J.; Li, X.; Jin, S.; Yu, L.; Liao, M.; Zhang, H.; Xu, C.; He, Q.; Wen, B.; Zhong, X.; Chen, X.; Chan, H. L.; Sung, J. J.; Zhou, B.; Ding, C. Multiplex detection of 60 hepatitis B virus variants by maldi-tof mass spectrometry. Clin.Chem., 2009, 55, 1503-1509.
274. Hong, S. P.; Kim, N. K.; Hwang, S. G.; Chung, H. J.; Kim, S.; Han, J. H.; Kim, H. T.; Rim, K. S.; Kang, M. S.; Yoo, W.; Kim, S.O. Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments J.Hepatol., 2004, 40, 837-844.
275. Sjoholm, M. I.; Dillner, J.; Carlson, J. Multiplex detection of human herpesviruses from archival specimens by using matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol., 2008, 46, 540-545.
276. Sharief, M. K.; Thompson, E. J. A sensitive ELISA system for the rapid detection of virus specific IgM antibodies in the cerebrospinal fluid. J. Immunol. Methods, 1990, 130, 19-24.
277. Solomon, T.; Thao, L. T.; Dung, N. M.; Kneen, R.; Hung, N. T.; Nisalak, A.; Vaughn, D. W.; Farrar, J.; Hien, T. T.; White, N. J.; Cardosa, M. J. Rapid diagnosis of Japanese encephalitis by using an immunoglobulin M dot enzyme immunoassay. J. Clin. Microbiol., 1998, 36, 2030-2034.
278. Burke, D. S.; Nisalak, A.; Ussery, M. A.; Laorakpongse, T.; Chantavibul, S. Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J. Infect.Dis., 1985, 151, 1093-1099.
279. Ravi, V.; Desai, A.; Balaji, M.; Apte, M. P.; Lakshman, L.; Subbakrishna, D. K.; Sridharan, G.; Dhole, T. N.; Ravikumar, B. V. Development and evaluation of a rapid IgM capture ELISA (JEV-Chex) for the diagnosis of Japanese encephalitis. J. Clin. Virol., 2006, 35, 429-434.
280. Lewthwaite, P.; Shankar, M. V.; Tio, P. H.; Daly, J.; Last, A.; Ravikumar, R.; Desai, A.; Ravi, V.; Cardosa, J. M.; Solomon, T. Evaluation of two commercially available ELISAs for the diagnosis of Japanese encephalitis applied to field samples. Trop. Med. Int. Health, 2010, 15, 811-818.
281. Lal, G.; Balmer, P.; Joseph, H.; Dawson, M.; Borrow, R. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135. Clin. Diagn. Lab. Immunol.,2004, 11, 272-279.
282. Laher, G.; Balmer, P.; Gray, S. J.; Dawson, M.; Kaczmarski, E. B.; Borrow, R. Development and evaluation of a rapid multianalyte particle-based flow cytometric assay for the quantification of meningococcal serogroup B-specific IgM antibodies in sera for nonculture case confirmation. FEMS Immunol. Med. Microbiol.,2006, 48, 34-43.
283. Wong, S. J.; Demarest, V. L.; Boyle, R. H.; Wang, T.; Ledizet, M.; Kar, K.; Kramer, L. D.; Fikrig, E.; Koski, R. A. Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay. J. Clin. Microbiol., 2004, 42, 65-72.
284. Johnson, A. J.; Cheshier, R. C.; Cosentino, G.; Masri, H. P.; Mock, V.; Oesterle, R.; Lanciotti, R. S.; Martin, D. A.; Panella, A. J.; Kosoy, O.; Biggerstaff, B. J. Validation of a microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin M antibodies. Clin. Vaccine Immunol., 2007, 14, 1084-1093.
285. Grossman, R. A.; Edelman, R.; Willhight, M.; Pantuwatana, S.; Udomsakdi, S. Study of Japanese encephalitis virus in Chiangmai Valley, Thailand. 3. Human seroepidemiology and inapparent infections. Am. J. Epidemiol., 1973, 98, 133-149.
286. Ramasundrum, V.; Tan, C. T.; Chong, H. T.; Goh, K. J.; Chew, N. K.; Petharunam, V.; Thayaparan, T.; Chua, K. B.; Lam, S. K.; Ksiazek, T. G. Presence of CSF IgM do not have protective effect in Nipah encephalitis. Neurol. J. Southeast Asia, 1999, 4, 73-76.
287. Holzmann, H., Diagnosis of tick-borne encephalitis. Vaccine, 2003, 21 Suppl 1, S36-S40.
288. Levine, D.; Lauter, C.; Lerner, M. Simultaneous serum and CSF antibodies in herpes simplex virus encephalitis. JAMA, 1978, 240, 356-360.
289. Chataway, J.; Davies, N. W.; Farmer, S.; Howard, R. S.; Thompson, E. J.; Ward, K. N. Herpes simplex encephalitis: an audit of the use of laboratory diagnostic tests. QJM, 2004, 97, 325-330.
290. Gregoire, S. M.; van Pesch, V.; Goffette, S.; Peeters, A.; Sindic, C. J. Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system. J. Neurol. Neurosurg. Psychiatry, 2006, 77, 938-942.
291. Reiber, H.; Peter, J. B. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J. Neurol. Sci., 2001, 184, 101-122.
292. Linde, A.; Klapper, P. E.; Monteyne, P.; Echevarria, J. M.; Cinque, P.; Rozenberg, F.; Vestergaard, B. F.; Ciardi, M.; Lebon, P.; Cleator, G. M. Specific diagnostic methods for herpesvirus infections of the central nervous system: a consensus review by the European Union Concerted Action on Virus Meningitis and Encephalitis. Clin.Diagn.Virol., 1997, 8, 83-104.
293. Monteyne, P.; Albert, F.; Weissbrich, B.; Zardini, E.; Ciardi, M.; Cleator, G. M.; Sindic, C. J. The detection of intrathecal synthesis of anti-herpes simplex IgG antibodies: comparison between an antigen-mediated immunoblotting technique and antibody index calculations. European Union Concerted Action on Virus Meningitis and Encephalitis. J. Med. Virol., 1997, 53, 324-331.
294. Tibbling, G.; Link, H.; Ohman, S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand. J. Clin. Lab. Invest., 1977, 37, 385-390.
295. Link, H.; Tibbling, G. Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid. Scand. J. Clin. Lab. Invest., 1977, 37, 391-396.
296. Klapper, P. E.; Laing, I.; Longson, M. Rapid non-invasive diagnosis of herpes encephalitis. Lancet, 1981, 2 (8247), 607-609.
297. Reiber, H.; Lange, P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin.Chem., 1991, 37, 1153-1160.
298. Schubert, J.; Weissbrich, B. Detection of virus-specific intrathecally synthesised immunoglobulin G with a fully automated enzyme immunoassay system. BMC Neurol., 2007, 7, 12.
299. Vandvik, B.; Skoldenberg, B.; Forsgren, M.; Stiernstedt, G.; Jeansson, S.; Norrby, E. Long-term persistence of intrathecal virus-specific antibody responses after herpes simplex virus encephalitis. J. Neurol., 1985, 231, 307-312.
300. Chen, W. J.; Hwang, K. P.; Fang, A. H. Detection of IgM antibodies from cerebrospinal fluid and sera of dengue fever patients. Southeast Asian J. Trop. Med. Public Health, 1991, 22, 659-663.
301. Vandvik, B.; Norrby, E.; Steen-Johnsen, J.; Stensvold, K. Mumps meningitis: prolonged pleocytosis and occurrence of mumps virus-specific oligoclonal IgG in the cerebrospinal fluid. Eur. Neurol., 1978, 17, 13-22.
302. Coghlan, J.; Monaghan, C.; Carney, P.; Moran, J. Is serodiagnosis of herpes simplex encephalitis safe? Postgrad. Med. J., 1987, 63, 973-974.
303. Keir, G.; Luxton, R. W.; Thompson, E. J. Isoelectric focusing of cerebrospinal fluid immunoglobulin G: an annotated update. Ann. Clin. Biochem., 1990, 27, 436-443.
304. Lunding, J.; Midgard, R.; Vedeler, C.A. Oligoclonal bands in cerebrospinal fluid: a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG index. Acta Neurol. Scand., 2000, 102, 322-325.
305. Luxton, R. W.; McLean, B. N.; Thompson, E. J. Isoelectric focusing versus quantitative measurements in the detection of intrathecal local synthesis of IgG. Clin. Chim. Acta, 1990, 187, 297-308.
306. Zeman, A.; McLean, B.; Keir, G.; Luxton, R.; Sharief, M.; Thompson, E. The significance of serum oligoclonal bands in neurological diseases. J. Neurol. Neurosurg. Psychiatry, 1993, 56, 32-35.
307. Kuhn, J. E.; Klaffke, K.; Munk, K.; Braun, R. W. HSV-1 gB and VZV gp-II crossreactive antibodies in human sera. Arch. Virol., 1990, 112, 203-213.
308. Casas, I.; Tenorio, A.; de Ory, F.; Lozano, A.; Echevarria, J. M. Detection of both herpes simplex and varicella-zoster viruses in cerebrospinal fluid from patients with encephalitis. J. Med. Virol., 1996, 50, 82-92.
309. Andersson, L.-M.; Blennow, K.; Fuchs, D.; Svennerholm, B.; Gisslen, M. Increased cerebrospinal fluid protein tau concentration in neuro-AIDS. J. Neurol. Sci.,1999, 171, 92-96.
310. Blennow, K.; Wallin, A.; Agren, A.; Spenger, C.; Siegfried, J.; Vanmechelen, E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol. Chemical Neuropathol., 1995, 26, 231-245.
311. Fjell, A.; Walhovd, K.; Fennema-Notestine, C.; McEvoy, L.; Hagler, D.; Holland, D.; Brewer, J.; Dale, A.; Initiative, A. s. D. N. CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. J. Neurosci., 2010, 30, 2088-2101.
312. Olsson, A.; Vanderstichele, H.; Andreasen, N.; De Meyer, G.; Wallin, A.; Holmberg, B.; Rosengren, L.; Vanmechelen, E.; Blennow, K. Simultaneous measurement of -amyloid(1-41), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin. Chem., 2005, 51, 336-345.
313. Miller, B.; Mandell, J. Multiplex method for measuring biomarkers of Alzheimer disease in cerebrospinal fluid. Clin. Chem., 2005, 51, 289-290.
314. Wu, W.; Xu, D. Z.; Yan, Y. P.; Zhang, J. X.; Liu, Y.; Li, R. L. Evaluation of dot immunogold filtration assay for anti-HAV IgM antibody. World J. Gastroenterol., 1999, 5, 132-134.
315. Beristain, C. N.; Rojkin, L. F.; Lorenzo, L. E. Evaluation of a dipstick method for the detection of human immunodeficiency virus infection. J. Clin. Lab. Anal., 1995, 9, 347-350.
316. Faulstich, K.; Gruler, R.; Eberhard, M.; Lentzsch, D.; Haberstroh, K. Handheld and Portable Reader Devices for Lateral Flow Immunoassays. In: Lateral Flow Immunoassay, Wong, R. C.; Tse, H. Y., Eds. Humana Press: New York, NY, 2009; pp 157-183.
317. Wang, H.; Feng, N.; Yang, S.; Wang, C.; Wang, T.; Gao, Y.; Su, J.; Zheng, X.; Hou, X.; Huang, H.; Yang, R.; Zou, X.; Huang, G.; Xia, X. A rapid immunochromatographic test strip for detecting rabies virus antibody. J. Virol. Methods, 2010, 170, 80-85.
318. Ukonaho, T.; Rantanen, T.; Jamsen, L.; Kuningas, K.; Pakkila, H.; Lovgren, T.; Soukka, T. Comparison of infrared-excited up-converting phosphors and europium nanoparticles as labels in a two-site immunoassay. Anal. Chim. Acta, 2007, 596, 106-115.
319. Eliseeva, S. V.; Bunzli, J. C. Lanthanide luminescence for functional materials and bio-sciences. Chem. Soc. Rev., 2010, 39, 189-227.
320. Corstjens, P.; Zuiderwijk, M.; Brink, A.; Li, S.; Feindt, H.; Niedbala, R. S.; Tanke, H. Use of up-converting phosphor reporters in lateral-flow assays to detect specific nucleic acid sequences: a rapid, sensitive DNA test to identify human papillomavirus type 16 infection. Clin. Chem., 2001, 47, 1885-1893.
321. Zuiderwijk, M.; Tanke, H. J.; Sam Niedbala, R.; Corstjens, P. L. An amplification-free hybridization-based DNA assay to detect Streptococcus pneumoniae utilizing the up-converting phosphor technology. Clin. Biochem., 2003, 36, 401-403.
322. Kessler, H. H.; Muhlbauer, G.; Rinner, B.; Stelzl, E.; Berger, A.; Dorr, H. W.; Santner, B.; Marth, E.; Rabenau, H. Detection of Herpes simplex virus DNA by real-time PCR. J. Clin. Microbiol., 2000, 38, 2638-2642.
323. Rand, K.; Houck, H.; Lawrence, R. Real-time polymerase chain reaction detection of herpes simplex virus in cerebrospinal fluid and cost savings from earlier hospital discharge. J. Mol. Diagn., 2005, 7, 511-516.
324. Wu, S. J.; Pal, S.; Ekanayake, S.; Greenwald, D.; Lara, S.; Raviprakash, K.; Kochel, T.; Porter, K.; Hayes, C.; Nelson, W.; Callahan, J. A dry-format field-deployable quantitative reverse transcriptase-polymerase chain reaction assay for diagnosis of dengue infections. Am. J. Trop. Med. Hyg., 2008, 79, 505-510.
325. Emanuel, P. A.; Fruchey, I. R. Biological Detectors. Market Survey.2007 edition. http://www.ecbc.army.mil/downloads/publications/MS_BD_07_lo w%20res.pdf.
326. Gavino, M.; Wang, E. A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization. Am. J. Obstet. Gynecol., 2007, 197, 388 e1-4.
327. Wolk, D. M.; Picton, E.; Johnson, D.; Davis, T.; Pancholi, P.; Ginocchio, C. C.; Finegold, S.; Welch, D. F.; de Boer, M.; Fuller, D.; Solomon, M. C.; Rogers, B.; Mehta, M. S.; Peterson, L. R. Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J. Clin. Microbiol., 2009, 47, 758-764.
328. Brenwald, N. P.; Baker, N.; Oppenheim, B. Feasibility study of a real-time PCR test for meticillin-resistant Staphylococcus aureus in a point of care setting. J. Hosp. Infect., 2010, 74, 245-249.
329. Marlowe, E. M.; Novak, S. M.; Dunn, J. J.; Smith, A.; Cumpio, J.; Makalintal, E.; Barnes, D.; Burchette, R. J. Performance of the GeneXpert enterovirus assay for detection of enteroviral RNA in cerebrospinal fluid. J.Clin.Virol., 2008, 43, 110-113.
330. Kost, C. B.; Rogers, B.; Oberste, M. S.; Robinson, C.; Eaves, B. L.; Leos, K.; Danielson, S.; Satya, M.; Weir, F.; Nolte, F. S. Multicenter beta trial of the GeneXpert enterovirus assay. J. Clin. Microbiol., 2007, 45 (4), 1081-1086.
331. Seme, K.; Mocilnik, T.; Komlos, K. F.; Doplihar, A.; Persing, D. H.; Poljak, M. GeneXpert enterovirus assay: one-year experience in a routine laboratory setting and evaluation on three proficiency panels. J. Clin. Microbiol., 2008, 46, 1510-1513.
332. Pillet, S.; Billaud, G.; Omar, S.; Lina, B.; Pozzetto, B.; Schuffenecker, I. Multicenter evaluation of the ENTEROVIRUS R-gene real-time RT-PCR assay for the detection of enteroviruses in clinical specimens. J.Clin.Virol., 2010, 47, 54-59.
333. Verpoorte, E. Microfluidic chips for clinical and forensic analysis. Electrophoresis, 2002, 23, 677-712.
334. Taylor, T. B.; Winn-Deen, E. S.; Picozza, E.; Woudenberg, T. M.; Albin, M. Optimization of the performance of the polymerase chain reaction in silicon-based microstructures. Nucleic Acids Res., 1997, 25, 3164-3168.
335. Belgrader, P.; Benett, W.; Hadley, D.; Richards, J.; Stratton, P.; Mariella, R., Jr.; Milanovich, F. PCR detection of bacteria in seven minutes. Science, 1999, 284, 449-450.
336. Zhang, Y.; Ozdemir, P. Microfluidic DNA amplification--a review. Anal. Chim. Acta., 2009, 638, 115-125.
337. Kim, J.; Johnson, M.; Hill, P.; Gale, B. K. Microfluidic sample preparation: cell lysis and nucleic acid purification. Integr. Biol. (Camb)., 2009, 1, 574-586.
338. Chen, X.; Cui da, F.; Liu, C. C. On-line cell lysis and DNA extraction on a microfluidic biochip fabricated by microelectromechanical system technology. Electrophoresis, 2008, 29, 1844-1851.
339. Singh-Zocchi, M.; Dixit, S.; Ivanov, V.; Zocchi, G. Single-molecule detection of DNA hybridization. Proc. Natl. Acad. Sci. USA, 2003, 100, 7605-7610.
340. Ligler, F. S. Perspective on optical biosensors and integrated sensor systems. Anal.Chem., 2009, 81, 519-526.
341. Fan, C.; Plaxco, K. W.; Heeger, A. J. Electrochemical interrogation of conformational changes as a reagentless method for the sequence-specific detection of DNA. Proc. Natl. Acad. Sci. USA, 2003, 100, 9134-9137.
342. Nakamura, N.; Ito, K.; Takahashi, M.; Hashimoto, K.; Kawamoto, M.; Yamanaka, M.; Taniguchi, A.; Kamatani, N.; Gemma, N. Detection of six single-nucleotide polymorphisms associated with rheumatoid arthritis by a loop-mediated isothermal amplification method and an electrochemical DNA chip. Anal.Chem., 2007, 79, 9484-9493.
343. Navani, N. K.; Li, Y. Nucleic acid aptamers and enzymes as sensors. Curr. Opin. Chem. Biol., 2006, 10, 272-281.
344. Mokany, E.; Bone, S. M.; Young, P. E.; Doan, T. B.; Todd, A. V. MNAzymes, a versatile new class of nucleic acid enzymes that can function as biosensors and molecular switches. J. Am. Chem. Soc., 2010, 132, 1051-1059.
345. Chang, Y.; Cesarman, E.; Pessin, M.; Lee, F.; Culpepper, J.; Knowles, D.; Moore, P. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 1994, 266 (5192), 1865-1869.
346. Nishizawa, T.; Okamoto, H.; Konishi, K.; Yoshizawa, H.; Miyakawa, Y.; Mayumi, M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem. Biophys. Res. Commun., 1997, 241, 92-97.
347. Allander, T.; Tammi, M.; Eriksson, M.; Bjerkner, A.; Tiveljung-Lindell, A.; Andersson, B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc. Natl. Acad. Sci. USA, 2005, 102, 12891-12896.
348. Allander, T.; Andreasson, K.; Gupta, S.; Bjerkner, A.; Bogdanovic, G.; Persson, M.; Dalianis, T.; Ramqvist, T.; Andersson, B. Identification of a third human polyomavirus. J.Virol., 2007, 81 (8), 4130-4136.
349. Jones, M.; Kapoor, A.; Lukashov, V.; Simmonds, P.; Hecht, F.; Delwart, E. New DNA viruses identified in patients with acute viral syndrome. J. Virol., 2005, 79, 8230-8236.
350. van der Hoek, L.; Pyrc, K.; Jebbink, M. F.; Vermeulen-Oost, W.; Berkhout, R. J.; Wolthers, K. C.; Wertheim-van Dillen, P. M.; Kaandorp, J.; Spaargaren, J.; Berkhout, B. Identification of a new human coronavirus. Nat. Med., 2004, 10, 368-373.
351. Ambrose, H.; Clewley, J. Virus discovery by sequence-independent genome amplification. Rev. Med. Virol., 2006, 16, 365-383.
352. Delwart, E. L. Viral metagenomics. Rev. Med. Virol., 2007, 17, 115-131.
353. Victoria, J. G.; Kapoor, A.; Dupuis, K.; Schnurr, D. P.; Delwart, E. L. Rapid identification of known and new RNA viruses from animal tissues. PLoS Pathog., 2008, 4, e1000163.
354. Mardis, E., The impact of next-generation sequencing technology on genetics. Trends Genet., 2008, 24, 133-141.
355. Ten Bosch, J. R.; Grody, W. W. Keeping up with the next generation: massively parallel sequencing in clinical diagnostics. J. Mol. Diagn., 2008, 10, 484-492.
356. Pettersson, E.; Lindskog, M.; Lundeberg, J.; Ahmadian, A. Tri-nucleotide threading for parallel amplification of minute amounts of genomic DNA. Nucleic Acids Res., 2006, 34, e49.
357. Davidson, I.; Shulman, L. M. Unraveling the puzzle of human anellovirus infections by comparison with avian infections with the chicken anemia virus. Virus. Res., 2008, 137, 1-15.
358. Venter, J. C.; Remington, K.; Heidelberg, J. F.; Halpern, A. L.; Rusch, D.; Eisen, J. A.; Wu, D.; Paulsen, I.; Nelson, K. E.; Nelson, W.; Fouts, D. E.; Levy, S.; Knap, A. H.; Lomas, M. W.; Nealson, K.; White, O.; Peterson, J.; Hoffman, J.; Parsons, R.; Baden-Tillson, H.; Pfannkoch, C.; Rogers, Y.-H.; Smith, H. O. Environmental genome shotgun sequencing of the Sargasso Sea. Science, 2004, 304, 66-74.
359. Rezza, G.; Nicoletti, L.; Angelini, R.; Romi, R.; Finarelli, A. C.; Panning, M.; Cordioli, P.; Fortuna, C.; Boros, S.; Magurano, F.; Silvi, G.; Angelini, P.; Dottori, M.; Ciufolini, M. G.; Majori, G. C.; Cassone, A. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet, 2007, 370, 1840-1846.
360. Gould, E.; Gallian, P.; De Lamballerie X.; Charrel R. First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality!. Clin. Microbiol. Infect., 2010, 16, 1702-1704.
361. Donoso Mantke, O.; Schadler, R.; Niedrig, M. A survey on cases of tick-borne encephalitis in European countries. Euro. Surveill., 2008, 13, pii: 18848.